Danhong Yang

Danhong Yang

Auto-generated profile, based on publicly available information

Danhong Yang

Zhejiang Provincal People's Hospital

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Medicine
Verified
Journal Article
Open access
PDF file
HHHaijun Huang
Haijun Huang
ZRZe-Ze Ren
Ze-Ze Ren
DYDai Yining
Dai Yining
YTYong-Xi Tong
Yong-Xi Tong
DYDan-Hong Yang
Dan-Hong Yang
HPHongying Pan
Hongying Pan
Tuberculous meningitis (TBM) is the most common form of central nervous system tuberculosis with a very poor prognosis. We aimed at assessing risk factors related to the prognosis of patients with TBM. Forty-five inpatients with TBM in our institution from January 2013 to December 2015 were enrolled retrospectively. The good or poor prognosis in the patients was defined, based on Glasgow Outcome Scale System at discharge. Patients with a GOS score less than 5 were defined as “poor prognosis.” Univariate and multivariate logistic regression analyses were performed to assess the predictors for TBM outcome. Among 45 TBM patients, 35 (77.8%) and 10 (22.2%) were in good, poor prognoses, respectively. Old age, disturbance of consciousness, moderate to severe electroencephalogram abnormality, hydrocephalus, remarkable increase of protein (≥ 236 mg/dL) and white blood cell counts (≥ 243 /μL) in cerebral spinal fluid were associated with poor prognosis. Multivariate analysis indicated that old age (odds ratio (OR) = 18.395, P = .036) and hydrocephalus (OR = 32.995, P = .049) were independent factors for a poor outcome of TBM. In conclusion, old age and hydrocephalus are the predictors for poor prognosis of TBM. Patients with these risk factors should be treated promptly with a special care paid to improve their outcomes.

5 June 2019 in Research Square
Verified
Preprint
Open access
DYDanhong Yang
Danhong Yang
YXYuanjun Xie
Yuanjun Xie
QZQiang Zhang
Qiang Zhang
YHYicheng Huang
Yicheng Huang
YDYining Dai
Yining Dai
HPHongying Pan
Hongying Pan
Background Systemic inflammatory response syndrome (SIRS) can cause serious negative effects among patients with liver cirrhosis (LC). . It is very important to finding methods for early diagnose and intervene early in these patients.This study was to assess the accuracy of early diagnostic value of serum biomarkers in patients with LC and SIRS. Methods A total of 123 LC patients were enrolled, 64 of whom were diagnosed with SIRS and 59 patients without SIRS. Various biomarkers and cytokines were measured in two groups of patients: LC+SIRS and LC−SIRS. Receiver operating characteristic curves (ROCs) were used to assess the ability of tested biomarkers to diagnoseLC with SIRS. Results White blood cell (WBC) count, neutrophil percentage(N%), as well as levels of C-reactive protein (CRP), procalcitonin(PCT), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), interleukin (IL)-6, IL-10 and tumor necrosis factor (TNF)-α, were significantly higher in the LC+SIRS group than in the LC−SIRS group. But only sTREM-1 had high accuracy of the early diagnosis for LC+SIRS. The WBC count, N% as well as levels of CRP, PCT, IL-6, andTNF-α had moderate diagnostic value, and IL-10 had low diagnostic value.The cutoff value of sTREM-1was 179.23 pg/mL and showed 84.4% sensitivity and 93.2% specificity.The AUC of sTREM-1 was 0.904(95%CI 0.899–0.982) and higher than that of the WBC count as well as levels of CRP, PCT, IL-6, IL-10 and TNF-α. In addition, 24 (37.50%) LC+SIRS cases died during 90-day follow-up. Neutrophil percentage as well as levels of CRP, PCT, sTREM-1, IL-6 and TNF-α were significantly higher those who died than in those who survived. Conclusion The WBC count,N% and levels of CRP, PCT, sTREM-1, IL-6, IL-10 and TNF-α are helpful for the early diagnosis of LC+SIRS.Serum sTREM-1 cut-off levels provide better accuracy than customary levels for cirrhosis with SIRS and appears to be a useful early marker to discriminate between SIRS and no-SIRS.It may also be helpful for implications in the prevention and treatment of cirrhosis and SIRS/sepsis.

16 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
DYDanhong Yang
Danhong Yang
QZQiang Zhang
Qiang Zhang
WWWeiping Wang
Weiping Wang
YHYicheng Huang
Yicheng Huang
HPHongying Pan
Hongying Pan
MWMiaomiao Wu
Miaomiao Wu
BackgroundSepsis is can cause serious negative effects among patients with cirrhosis.Finding reliable biomarker in early diagnose and prognosis in septic patients with liver cirrhosis is very important.We assessed value of serumsoluble triggering receptor expressed on myeloid cells-1 ( sTREM-1),D-lactate and Intestinal fatty acid binding protein(I-FABP) in diagnosis and prognosis evaluation in liver cirrhotic patients with sepsis.MethodsA prospective observational study of 158 cirrhosis patients was conducted. A total of 158cirrhosis patients were enrolled, 83 of whom were diagnosed with sepsis and 75 patients without sepsis during hospitalization.We evaluated value of early diagnostic and prognosis of cells-1(sTREM-1),D-lactate and I-FABP in cirrhotic patients with sepsis.Receiver operating characteristic curves (ROCs) were used to assess the ability of tested biomarkers to diagnose and prognosis cirrhotic patients with sepsis.ResultsOur results showed the CRP,PCT,sTREM-1, D-lactate and I-FABP were significantly higher in the sepsis group than in the no-sepsis group.,but only levels of serum sTREM-1 showed increasing trend with the severity of the cirrhotic patients with sepsis. The cutoff value of sTREM-1was 123.62 pg/mL and showed 84.3% sensitivity and 92.0% specificity and high accuracy in the early diagnosis for cirrhotic patients with sepsis.The AUC of sTREM-1 was 0.959(95%CI: 0.934–0. 985) and higher than that of CRP,PCT,D-lactate and I-FABP( P <0.001, P =0.002, P <0.001, P <0.001 respectively).Total 31(37.35%) cirrhotic patients with sepsis cases died during 90-day follow-up.Only sTREM-1 level had significance between survivors and non-survivors(263.99±213.79 vs 672.24±191.44,P=0.031).The AUCs of sTREM-1 for predicting 90-day mortality was 0.904( 95% CI:0.836-.971 ) and higher than that of CRP,PCT,D-lactate (P=0.001,p=0.003, P <0.001 respectively) The AUCs of I-FABP is only 0.482 and had no value of predicting prognosis.ConclusionSerum sTREM-1 is a valuable new biomarker for early diagnosis and prognosis in cirrhosis with sepsis, proving more accurate than CRP,PCT, D - lactate and I - FABP.Serum D-lactate and I-FABP levels can identify early cirrhosis with sepsis, but they is little relationship with the prognosis of patients.